KAROLINSKA INSTITUTET Early intervention with rituximab, a drug used in the treatment of rheumatoid arthritis (RA), can reduce the risk of deterioration in myasthenia gravis, an autoimmune disease that causes loss of muscle control. This is according to a randomised clinical study led by researchers at Karolinska Institutet in Sweden and published in the journal JAMA...
Tag: <span>rheumatoid arthritis drug</span>
Post
New rheumatoid arthritis drug passes Phase 3 trial, looks to approval
By Rich Haridy August 25, 2022 The new treatment is hoped to be available within the next 12 months Depositphotos Research published in The New England Journal of Medicine has reported positive Phase 3 trial results for a new monoclonal antibody treatment targeting rheumatoid arthritis. The novel therapy is hoped to offer a new option for patients...